Skip to main content

PROCEDURA NEGOZIATA SENZA PUBBLICAZIONE DI UN BANDO AI SENSI DELL'ART. 76, CO. 2, LETT. B, NUMERO 2) DEL D. LGS. N. 36/2023, PER L'ACQUISTO DEL FARMACO UNICO ZALTRAP*EV 1FL8ML200MG 25MG/ML, PRINCIPIO ATTIVO AFLIBERCEPT, ATC L01XX44, AIC 042689036, FORMA FARMACEUTICA CONC. PER SOL. INFUSIONE E.V., DOSAGGIO 1FL8ML200MG 25MG/ML E DEL FARMACO UNICO ZALTRAP*EV 1FL4ML100MG 25MG/ML, PRINCIPIO ATTIVO AFLIBERCEPT, ATC L01XX44, AIC 042689012, FORMA FARMACEUTICA CONC. PER SOL. INFUSIONE E.V. DOSAGGIO 1FL4ML100MG 25MG/ML

AZIENDA SANITARIA LOCALE BT

CIG B554BAD04BVerify on ANACApulia · TraniGoods / suppliesCompetitive dialogueCPV 33690000Risk signal — not an accusation of crime.
At a glance
Key figures from open ANAC records for this contract.

Amount

€212,269

Award date

14 Feb 2025

Bids

1

Published

23 Jan 2025

Estimated tender value

€213,000
Timeline
  1. Publication / start of procedure

    23 Jan 2025

    Step completed
  2. Time to submit bids

    30 Jan 2025

    7 days between opening and deadline

    Step completed
  3. Award

    14 Feb 2025

In plain language

These are automated checks on public data. They help you decide what to look into — they are not criminal findings.

This contract triggered 4 pattern(s) worth a closer look:

Low competition · Tight deadlines

Contracting authority (buyer)
Awarded to (suppliers)
1 award line(s) on record.
SupplierRegionAmountAward dateStatus
SANOFI S.R.L.€212,26914 Feb 2025AGGIUDICATA
How do I verify this tender?

Loading actions…

Similar tenders in the same area

Loading comparison…

Sector comparison

Loading…

Amount vs category

Loading…

Citizen verifier notes
Share what you verified on official sources — not a verdict
How the score is built
Ruleset 2.0.0 · 18 Jul 2026
Source data & verification

ANAC BDNCP — dati tabellari

Verify on ANAC

Ingested: 6 Jul 2026

Release: 20260501-cig_csv.csv

Days to submit bids: 7

PROCEDURA NEGOZIATA SENZA PUBBLICAZIONE DI UN BANDO AI SENSI DELL'ART. 76, CO. 2, LETT. B, NUMERO 2) DEL D. LGS. N. 36/2023, PER L'ACQUISTO DEL FARMACO UNICO ZALTRAP*EV 1FL8ML200MG 25MG/ML, PRINCIPIO ATTIVO AFLIBERCEPT, ATC L01XX44, AIC 042689036, FORMA FARMACEUTICA CONC. PER SOL. INFUSIONE E.V., DOSAGGIO 1FL8ML200MG 25MG/ML E DEL FARMACO UNICO ZALTRAP*EV 1FL4ML100MG 25MG/ML, PRINCIPIO ATTIVO AFLIBERCEPT, ATC L01XX44, AIC 042689012, FORMA FARMACEUTICA CONC. PER SOL. INFUSIONE E.V. DOSAGGIO 1FL4ML100MG 25MG/ML — AppaltiWatch